ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Activin RIIA

Activin RIIA

概要

Name:Activin receptor type-2A
Target Synonym:Activin receptor type IIA,ACTR-IIA,ACTRIIA,ACVR2
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

製品リスト製品比較と製品注文

ACRO Quality

生物活性データの一部

ACA-H5243-SPR
 Activin RIIA SPR

Human Activin RIIA Protein, His Tag (Cat. No. ACA-H5243) immobilized on CM5 Chip can bind Human Activin A Protein, premium grade (Cat. No. ACA-H5314) with an affinity constant of 85.9 pM as determined in a SPR assay (Biacore 8K) (QC tested).

ACA-M52H3-SPR
 Activin RIIA SPR

Mouse Activin RIIA Protein, His Tag (Cat. No. ACA-M52H3) capture on NTA-Series S sensor chip can bind Human Activin A Protein, Tag Free (Cat. No. ACA-H421b) with an affinity constant of 83.8 pM as determined in a SPR assay (Biacore 8K) (QC tested).

カスタマーレビュー

Synonym Name

Activin receptor type IIA,ACTRIIA

Background

Activin receptor type-2A (ACVR2A) is also known as Activin receptor type IIA, ACTR-IIA, ACTRIIA and ACVR2,which is single-pass type I membrane protein. ACVR2A belongs to the protein kinase superfamily,TKL Ser/Thr protein kinase family and TGFB receptor subfamily.On ligand binding,ACVR2A can forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators.ACVR2A is Receptor for activin A, activin B and inhibin A as well. Several type I I activin receptors have been identified and bind to different activins with different affinities.

Clinical and Translational Updates

相関分子

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
LAE-102 LAE-102 Phase 2 Clinical Laekna Therapeutics Shanghai Co Ltd Solid tumours; Metabolic Dysfunction-Associated Steatotic Liver Disease; Carcinoma, Non-Small-Cell Lung Details
LAE-123 LAE-123 Details
LAE-102 LAE-102 Phase 2 Clinical Laekna Therapeutics Shanghai Co Ltd Solid tumours; Metabolic Dysfunction-Associated Steatotic Liver Disease; Carcinoma, Non-Small-Cell Lung Details
LAE-123 LAE-123 Details

This web search service is supported by Google Inc.

totopphone